speb/financial-data huggingface dataset:
PLRX balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 1040000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 1040000.00
PLRX income_statement (annual, 2025-12-31) — Basic Average Shares: 61366887.00
PLRX income_statement (quarterly, 2025-12-31) — Basic Average Shares: 61449290.00
PLRX income_statement (annual, 2025-12-31) — Basic EPS: -2.43
PLRX income_statement (quarterly, 2025-12-31) — Basic EPS: -0.38
PLRX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 72670000.00
PLRX cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 95214000.00
PLRX cash_flow (annual, 2025-12-31) — Capital Expenditure: -374000.00
PLRX balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 29105000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 29105000.00
PLRX balance_sheet (annual, 2025-12-31) — Capital Stock: 6000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 6000.00
PLRX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 45445000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 45445000.00
PLRX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 190944000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 190944000.00
PLRX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -31697000.00
PLRX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -32267000.00
PLRX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 134290000.00
PLRX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 1768000.00
PLRX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -128336000.00
PLRX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -17788000.00
PLRX cash_flow (annual, 2025-12-31) — Change In Account Payable: -5480000.00
PLRX cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -3000.00
PLRX cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -12167000.00
PLRX cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -1514000.00
PLRX cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 43000.00
PLRX cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 0.00
PLRX cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -876000.00
PLRX cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -313000.00
PLRX cash_flow (annual, 2025-12-31) — Change In Payable: -5480000.00
PLRX cash_flow (quarterly, 2025-12-31) — Change In Payable: -3000.00
PLRX cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -17647000.00
PLRX cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -1517000.00
PLRX cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 2541000.00
PLRX cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -209000.00
PLRX cash_flow (annual, 2025-12-31) — Change In Working Capital: -15939000.00
PLRX cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -2039000.00
PLRX cash_flow (annual, 2025-12-31) — Changes In Cash: -25743000.00
PLRX cash_flow (quarterly, 2025-12-31) — Changes In Cash: -48287000.00
PLRX balance_sheet (annual, 2025-12-31) — Common Stock: 6000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Common Stock: 6000.00
PLRX balance_sheet (annual, 2025-12-31) — Common Stock Equity: 181205000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 181205000.00
PLRX cash_flow (annual, 2025-12-31) — Common Stock Issuance: 570000.00
PLRX cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
PLRX balance_sheet (annual, 2025-12-31) — Construction In Progress: 153000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 153000.00
PLRX balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 6140000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 6140000.00
PLRX balance_sheet (annual, 2025-12-31) — Current Assets: 196448000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Current Assets: 196448000.00
PLRX balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 1447000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 1447000.00
PLRX balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1447000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1447000.00
PLRX balance_sheet (annual, 2025-12-31) — Current Liabilities: 16365000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 16365000.00
PLRX cash_flow (annual, 2025-12-31) — Depreciation: 1696000.00
PLRX cash_flow (quarterly, 2025-12-31) — Depreciation: 365000.00
PLRX cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1696000.00
PLRX cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 365000.00
PLRX cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1696000.00
PLRX cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 365000.00
PLRX income_statement (annual, 2025-12-31) — Diluted Average Shares: 61366887.00
PLRX income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 61449290.00
PLRX income_statement (annual, 2025-12-31) — Diluted EPS: -2.43
PLRX income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.38
PLRX income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -149344000.00
PLRX income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -23577000.00
PLRX income_statement (annual, 2025-12-31) — EBIT: -146785000.00
PLRX income_statement (quarterly, 2025-12-31) — EBIT: -23441000.00
PLRX income_statement (annual, 2025-12-31) — EBITDA: -145089000.00
PLRX income_statement (quarterly, 2025-12-31) — EBITDA: -23076000.00
PLRX cash_flow (annual, 2025-12-31) — End Cash Position: 46927000.00
PLRX cash_flow (quarterly, 2025-12-31) — End Cash Position: 46927000.00
PLRX cash_flow (annual, 2025-12-31) — Financing Cash Flow: -31697000.00
PLRX cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -32267000.00
PLRX cash_flow (annual, 2025-12-31) — Free Cash Flow: -128710000.00
PLRX cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -17788000.00
PLRX cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -44000.00
PLRX cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 0.00
PLRX balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -15000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -15000.00
PLRX income_statement (annual, 2025-12-31) — General And Administrative Expense: 47216000.00
PLRX income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 7992000.00
PLRX balance_sheet (annual, 2025-12-31) — Gross PPE: 37775000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 37775000.00
PLRX income_statement (annual, 2025-12-31) — Interest Expense: 2559000.00
PLRX income_statement (quarterly, 2025-12-31) — Interest Expense: 136000.00
PLRX income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 2559000.00
PLRX income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 136000.00
PLRX income_statement (annual, 2025-12-31) — Interest Income: 11416000.00
PLRX income_statement (quarterly, 2025-12-31) — Interest Income: 1964000.00
PLRX income_statement (annual, 2025-12-31) — Interest Income Non Operating: 11416000.00
PLRX income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 1964000.00
PLRX cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 2539000.00
PLRX cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 347000.00
PLRX balance_sheet (annual, 2025-12-31) — Invested Capital: 181205000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 181205000.00
PLRX cash_flow (annual, 2025-12-31) — Investing Cash Flow: 134290000.00
PLRX cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 1768000.00
PLRX cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 570000.00
PLRX cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
PLRX cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
PLRX cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
PLRX balance_sheet (annual, 2025-12-31) — Leases: 2156000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Leases: 2156000.00
PLRX balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 27658000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 27658000.00
PLRX balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 27658000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 27658000.00
PLRX cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
PLRX cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
PLRX cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -32267000.00
PLRX balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 2937000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 2937000.00
PLRX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 570000.00
PLRX cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
PLRX income_statement (annual, 2025-12-31) — Net Income: -149344000.00
PLRX income_statement (quarterly, 2025-12-31) — Net Income: -23577000.00
PLRX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -149344000.00
PLRX income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -23577000.00
PLRX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -149344000.00
PLRX income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -23577000.00
PLRX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -149344000.00
PLRX income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -23577000.00
PLRX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -149344000.00
PLRX income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -23577000.00
PLRX cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -149344000.00
PLRX cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -23577000.00
PLRX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -149344000.00
PLRX income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -23577000.00
PLRX income_statement (annual, 2025-12-31) — Net Interest Income: 8857000.00
PLRX income_statement (quarterly, 2025-12-31) — Net Interest Income: 1828000.00
PLRX cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 134509000.00
PLRX cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 1769000.00
PLRX cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -32267000.00
PLRX cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -32267000.00
PLRX cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -32267000.00
PLRX cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -32267000.00
PLRX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 8857000.00
PLRX income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 1828000.00
PLRX balance_sheet (annual, 2025-12-31) — Net PPE: 26906000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Net PPE: 26906000.00
PLRX cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -219000.00
PLRX cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -1000.00
PLRX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 181205000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 181205000.00
PLRX income_statement (annual, 2025-12-31) — Normalized EBITDA: -143261000.00
PLRX income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -23076000.00
PLRX income_statement (annual, 2025-12-31) — Normalized Income: -147516000.00
PLRX income_statement (quarterly, 2025-12-31) — Normalized Income: -23577000.00
PLRX cash_flow (annual, 2025-12-31) — Operating Cash Flow: -128336000.00
PLRX cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -17788000.00
PLRX cash_flow (annual, 2025-12-31) — Operating Gains Losses: 1784000.00
PLRX cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 1828000.00
PLRX income_statement (annual, 2025-12-31) — Operating Income: -156373000.00
PLRX income_statement (quarterly, 2025-12-31) — Operating Income: -23577000.00
PLRX income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
PLRX income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
PLRX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 61449290.00
PLRX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 61449290.00
PLRX balance_sheet (annual, 2025-12-31) — Other Current Assets: 92000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 92000.00
PLRX balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -15000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -15000.00
PLRX income_statement (annual, 2025-12-31) — Other Gand A: 47216000.00
PLRX income_statement (quarterly, 2025-12-31) — Other Gand A: 7992000.00
PLRX income_statement (annual, 2025-12-31) — Other Income Expense: -1828000.00
PLRX cash_flow (annual, 2025-12-31) — Other Non Cash Items: 3277000.00
PLRX cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 828000.00
PLRX balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 1874000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 1874000.00
PLRX balance_sheet (annual, 2025-12-31) — Other Properties: 32529000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Other Properties: 32529000.00
PLRX balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 145499000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 145499000.00
PLRX income_statement (annual, 2025-12-31) — Other Special Charges: 1828000.00
PLRX balance_sheet (annual, 2025-12-31) — Payables: 480000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Payables: 480000.00
PLRX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 6620000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 6620000.00
PLRX balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 8298000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 8298000.00
PLRX balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
PLRX balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
PLRX balance_sheet (annual, 2025-12-31) — Prepaid Assets: 3549000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 3549000.00
PLRX income_statement (annual, 2025-12-31) — Pretax Income: -149344000.00
PLRX income_statement (quarterly, 2025-12-31) — Pretax Income: -23577000.00
PLRX balance_sheet (annual, 2025-12-31) — Properties: 0.00
PLRX balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
PLRX cash_flow (annual, 2025-12-31) — Purchase Of Investment: -203404000.00
PLRX cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -85085000.00
PLRX cash_flow (annual, 2025-12-31) — Purchase Of PPE: -374000.00
PLRX cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: 0.00
PLRX balance_sheet (annual, 2025-12-31) — Receivables: 823000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Receivables: 823000.00
PLRX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1696000.00
PLRX income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 365000.00
PLRX cash_flow (annual, 2025-12-31) — Repayment Of Debt: -32267000.00
PLRX income_statement (annual, 2025-12-31) — Research And Development: 109157000.00
PLRX income_statement (quarterly, 2025-12-31) — Research And Development: 15585000.00
PLRX balance_sheet (annual, 2025-12-31) — Retained Earnings: -859396000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -859396000.00
PLRX cash_flow (annual, 2025-12-31) — Sale Of Investment: 337913000.00
PLRX cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 86854000.00
PLRX cash_flow (annual, 2025-12-31) — Sale Of PPE: 155000.00
PLRX cash_flow (quarterly, 2025-12-31) — Sale Of PPE: -1000.00
PLRX income_statement (annual, 2025-12-31) — Selling General And Administration: 47216000.00
PLRX income_statement (quarterly, 2025-12-31) — Selling General And Administration: 7992000.00
PLRX balance_sheet (annual, 2025-12-31) — Share Issued: 61449290.00
PLRX balance_sheet (quarterly, 2025-12-31) — Share Issued: 61449290.00
PLRX income_statement (annual, 2025-12-31) — Special Income Charges: -1828000.00
PLRX cash_flow (annual, 2025-12-31) — Stock Based Compensation: 26234000.00
PLRX cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 4525000.00
PLRX balance_sheet (annual, 2025-12-31) — Stockholders Equity: 181205000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 181205000.00
PLRX balance_sheet (annual, 2025-12-31) — Tangible Book Value: 181205000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 181205000.00
PLRX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
PLRX income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
PLRX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
PLRX income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
PLRX balance_sheet (annual, 2025-12-31) — Total Assets: 225228000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Total Assets: 225228000.00
PLRX balance_sheet (annual, 2025-12-31) — Total Capitalization: 181205000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 181205000.00
PLRX balance_sheet (annual, 2025-12-31) — Total Debt: 29105000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Total Debt: 29105000.00
PLRX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 181205000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 181205000.00
PLRX income_statement (annual, 2025-12-31) — Total Expenses: 156373000.00
PLRX income_statement (quarterly, 2025-12-31) — Total Expenses: 23577000.00
PLRX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 44023000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 44023000.00
PLRX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 28780000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 28780000.00
PLRX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 27658000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 27658000.00
PLRX income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -156373000.00
PLRX income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -23577000.00
PLRX income_statement (annual, 2025-12-31) — Total Unusual Items: -1828000.00
PLRX income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -1828000.00
PLRX balance_sheet (annual, 2025-12-31) — Working Capital: 180083000.00
PLRX balance_sheet (quarterly, 2025-12-31) — Working Capital: 180083000.00
PLRX income_statement (quarterly, 2026-03-31) — +Operating Expense: 21772000.00
PLRX income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
PLRX balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 362000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Accrued Interest Receivable: 914000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -10439000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 1044937000.00
PLRX cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: 417000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 906000.00
PLRX income_statement (quarterly, 2026-03-31) — Basic Average Shares: 61803467.00
PLRX income_statement (quarterly, 2026-03-31) — Basic EPS: -0.32
PLRX cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 46927000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 28784000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Capital Stock: 6000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 22190000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 170892000.00
PLRX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 74000.00
PLRX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -4100000.00
PLRX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -19229000.00
PLRX cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -118000.00
PLRX cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -6474000.00
PLRX cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 323000.00
PLRX cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -320000.00
PLRX cash_flow (quarterly, 2026-03-31) — Change In Payable: -118000.00
PLRX cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -6592000.00
PLRX cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 1724000.00
PLRX cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -4865000.00
PLRX cash_flow (quarterly, 2026-03-31) — Changes In Cash: -23255000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Common Stock: 6000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 165166000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 153000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 5992000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Current Assets: 174930000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 1713000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1713000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 10359000.00
PLRX cash_flow (quarterly, 2026-03-31) — Depreciation: 264000.00
PLRX cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 264000.00
PLRX cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 264000.00
PLRX income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 61803467.00
PLRX income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.32
PLRX income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -20040000.00
PLRX income_statement (quarterly, 2026-03-31) — EBIT: -20040000.00
PLRX income_statement (quarterly, 2026-03-31) — EBITDA: -19776000.00
PLRX cash_flow (quarterly, 2026-03-31) — End Cash Position: 23672000.00
PLRX cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 74000.00
PLRX cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -19229000.00
PLRX cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: -94000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -341000.00
PLRX income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 8188000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Gross PPE: 36234000.00
PLRX income_statement (quarterly, 2026-03-31) — Interest Expense: 0.00
PLRX income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 0.00
PLRX income_statement (quarterly, 2026-03-31) — Interest Income: 1732000.00
PLRX income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 1732000.00
PLRX cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 0.00
PLRX balance_sheet (quarterly, 2026-03-31) — Invested Capital: 165166000.00
PLRX cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -4100000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Leases: 2156000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 27071000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 27071000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 2937000.00
PLRX income_statement (quarterly, 2026-03-31) — Net Income: -20040000.00
PLRX income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -20040000.00
PLRX income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -20040000.00
PLRX income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -20040000.00
PLRX income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -20040000.00
PLRX cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -20040000.00
PLRX income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -20040000.00
PLRX income_statement (quarterly, 2026-03-31) — Net Interest Income: 1732000.00
PLRX cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -4202000.00
PLRX income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 1732000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Net PPE: 25795000.00
PLRX cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 102000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 165166000.00
PLRX income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -19776000.00
PLRX income_statement (quarterly, 2026-03-31) — Normalized Income: -20040000.00
PLRX cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -19229000.00
PLRX cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -94000.00
PLRX income_statement (quarterly, 2026-03-31) — Operating Income: -21772000.00
PLRX income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
PLRX balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 61914569.00
PLRX balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 257000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -341000.00
PLRX income_statement (quarterly, 2026-03-31) — Other Gand A: 8188000.00
PLRX cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 835000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1871000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Other Properties: 30988000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 148702000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Payables: 362000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 6354000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 2291000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
PLRX balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 1961000.00
PLRX income_statement (quarterly, 2026-03-31) — Pretax Income: -20040000.00
PLRX cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 74000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
PLRX cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -64900000.00
PLRX cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: 0.00
PLRX balance_sheet (quarterly, 2026-03-31) — Receivables: 914000.00
PLRX income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 264000.00
PLRX income_statement (quarterly, 2026-03-31) — Research And Development: 13584000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -879436000.00
PLRX cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 60698000.00
PLRX cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 102000.00
PLRX income_statement (quarterly, 2026-03-31) — Selling General And Administration: 8188000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Share Issued: 61914569.00
PLRX cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 4254000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 165166000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 165166000.00
PLRX income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
PLRX income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
PLRX balance_sheet (quarterly, 2026-03-31) — Total Assets: 202596000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 165166000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Total Debt: 28784000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 165166000.00
PLRX income_statement (quarterly, 2026-03-31) — Total Expenses: 21772000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 37430000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 27666000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 27071000.00
PLRX income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -21772000.00
PLRX balance_sheet (quarterly, 2026-03-31) — Working Capital: 164571000.00
PLRZ income_statement (annual, 2022-12-31) — +Operating Expense: 895000.00
PLRZ income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
PLRZ balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 2021000.00
PLRZ income_statement (annual, 2022-12-31) — Basic Average Shares: 2796.00
PLRZ income_statement (annual, 2022-12-31) — Basic EPS: -294.35
PLRZ cash_flow (annual, 2022-12-31) — Beginning Cash Position: 523000.00
PLRZ cash_flow (annual, 2022-12-31) — Capital Expenditure: -3000.00
PLRZ balance_sheet (annual, 2022-12-31) — Capital Stock: 0.00
PLRZ balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 36000.00
PLRZ balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 36000.00
PLRZ cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 648000.00
PLRZ cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -3000.00
PLRZ cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -1132000.00
PLRZ cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -15000.00
PLRZ cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 6000.00
PLRZ cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -335000.00
PLRZ cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -15000.00
PLRZ cash_flow (annual, 2022-12-31) — Change In Working Capital: -344000.00
PLRZ cash_flow (annual, 2022-12-31) — Changes In Cash: -487000.00
PLRZ balance_sheet (annual, 2022-12-31) — Common Stock: 0.00
PLRZ balance_sheet (annual, 2022-12-31) — Common Stock Equity: -900000.00
PLRZ cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
PLRZ balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 141000.00
PLRZ balance_sheet (annual, 2022-12-31) — Current Assets: 51000.00
PLRZ balance_sheet (annual, 2022-12-31) — Current Debt: 622000.00
PLRZ balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 622000.00
PLRZ balance_sheet (annual, 2022-12-31) — Current Liabilities: 1198000.00
PLRZ cash_flow (annual, 2022-12-31) — Depreciation: 5000.00
PLRZ cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 5000.00
PLRZ cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 5000.00
PLRZ income_statement (annual, 2022-12-31) — Diluted Average Shares: 2796.00
PLRZ income_statement (annual, 2022-12-31) — Diluted EPS: -294.35
PLRZ income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -823000.00
PLRZ income_statement (annual, 2022-12-31) — EBIT: -895000.00
PLRZ income_statement (annual, 2022-12-31) — EBITDA: -890000.00
PLRZ cash_flow (annual, 2022-12-31) — End Cash Position: 36000.00
PLRZ cash_flow (annual, 2022-12-31) — Financing Cash Flow: 648000.00
PLRZ cash_flow (annual, 2022-12-31) — Free Cash Flow: -1135000.00
PLRZ cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -118000.00
PLRZ income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 92000.00
PLRZ income_statement (annual, 2022-12-31) — General And Administrative Expense: 533000.00
PLRZ balance_sheet (annual, 2022-12-31) — Invested Capital: -278000.00
PLRZ cash_flow (annual, 2022-12-31) — Investing Cash Flow: -3000.00
PLRZ cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
PLRZ cash_flow (annual, 2022-12-31) — Issuance Of Debt: 648000.00
PLRZ cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
PLRZ cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
PLRZ cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
PLRZ balance_sheet (annual, 2022-12-31) — Net Debt: 586000.00
PLRZ income_statement (annual, 2022-12-31) — Net Income: -779000.00
PLRZ income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -823000.00
PLRZ income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -779000.00
PLRZ income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -779000.00
PLRZ income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -779000.00
PLRZ cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -779000.00
PLRZ income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -779000.00
PLRZ income_statement (annual, 2022-12-31) — Net Interest Income: 24000.00
PLRZ cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 0.00
PLRZ cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 648000.00
PLRZ cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 0.00
PLRZ income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 24000.00
PLRZ balance_sheet (annual, 2022-12-31) — Net PPE: 16000.00
PLRZ cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -3000.00
PLRZ cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 648000.00
PLRZ balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -900000.00
PLRZ balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 479000.00
PLRZ income_statement (annual, 2022-12-31) — Normalized EBITDA: -982000.00
PLRZ income_statement (annual, 2022-12-31) — Normalized Income: -871000.00
PLRZ cash_flow (annual, 2022-12-31) — Operating Cash Flow: -1132000.00
PLRZ cash_flow (annual, 2022-12-31) — Operating Gains Losses: -118000.00
PLRZ income_statement (annual, 2022-12-31) — Operating Income: -895000.00
PLRZ income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
PLRZ balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 2796.00
PLRZ balance_sheet (annual, 2022-12-31) — Other Current Assets: 15000.00
PLRZ balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 622000.00
PLRZ balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 398000.00
PLRZ income_statement (annual, 2022-12-31) — Other Gand A: 343000.00
PLRZ income_statement (annual, 2022-12-31) — Other Income Expense: 92000.00
PLRZ cash_flow (annual, 2022-12-31) — Other Non Cash Items: -26000.00
PLRZ balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 0.00
PLRZ balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 141000.00
PLRZ balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 37000.00
PLRZ balance_sheet (annual, 2022-12-31) — Preferred Securities Outside Stock Equity: 248000.00
PLRZ income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 44000.00
PLRZ income_statement (annual, 2022-12-31) — Pretax Income: -779000.00
PLRZ cash_flow (annual, 2022-12-31) — Purchase Of PPE: -3000.00
PLRZ income_statement (annual, 2022-12-31) — Reconciled Depreciation: 5000.00
PLRZ cash_flow (annual, 2022-12-31) — Repayment Of Debt: 0.00
PLRZ income_statement (annual, 2022-12-31) — Research And Development: 347000.00
PLRZ balance_sheet (annual, 2022-12-31) — Retained Earnings: -2921000.00
PLRZ income_statement (annual, 2022-12-31) — Salaries And Wages: 190000.00
PLRZ cash_flow (annual, 2022-12-31) — Sale Of Investment: 0.00
PLRZ income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 15000.00
PLRZ income_statement (annual, 2022-12-31) — Selling General And Administration: 548000.00
PLRZ balance_sheet (annual, 2022-12-31) — Share Issued: 2796.00
PLRZ cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 648000.00
PLRZ cash_flow (annual, 2022-12-31) — Stock Based Compensation: 130000.00
PLRZ balance_sheet (annual, 2022-12-31) — Stockholders Equity: -900000.00
PLRZ balance_sheet (annual, 2022-12-31) — Tangible Book Value: -900000.00
PLRZ income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
PLRZ income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
PLRZ balance_sheet (annual, 2022-12-31) — Total Assets: 546000.00
PLRZ balance_sheet (annual, 2022-12-31) — Total Capitalization: -900000.00
PLRZ balance_sheet (annual, 2022-12-31) — Total Debt: 622000.00
PLRZ balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: -900000.00
PLRZ income_statement (annual, 2022-12-31) — Total Expenses: 895000.00
PLRZ balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 1446000.00
PLRZ balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 495000.00
PLRZ balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 248000.00
PLRZ income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -895000.00
PLRZ income_statement (annual, 2022-12-31) — Total Other Finance Cost: -24000.00
PLRZ income_statement (annual, 2022-12-31) — Total Unusual Items: 92000.00
PLRZ income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 92000.00
PLRZ cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
PLRZ balance_sheet (annual, 2022-12-31) — Working Capital: -1147000.00
PLRZ income_statement (annual, 2023-12-31) — +Operating Expense: 635000.00
PLRZ income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
PLRZ balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 3526000.00
PLRZ income_statement (annual, 2023-12-31) — Basic Average Shares: 2796.00
PLRZ income_statement (annual, 2023-12-31) — Basic EPS: -239.27
PLRZ cash_flow (annual, 2023-12-31) — Beginning Cash Position: 36000.00
PLRZ balance_sheet (annual, 2023-12-31) — Capital Stock: 0.00
PLRZ balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 4000.00
PLRZ balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 41000.00
PLRZ cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 505000.00
PLRZ cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 0.00
PLRZ cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -537000.00
PLRZ cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 17000.00
PLRZ cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 2000.00
PLRZ cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -12000.00
PLRZ cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 17000.00
PLRZ cash_flow (annual, 2023-12-31) — Change In Working Capital: 7000.00
PLRZ cash_flow (annual, 2023-12-31) — Changes In Cash: -32000.00
PLRZ balance_sheet (annual, 2023-12-31) — Common Stock: 0.00
PLRZ balance_sheet (annual, 2023-12-31) — Common Stock Equity: -191000.00
PLRZ cash_flow (annual, 2023-12-31) — Common Stock Issuance: 256000.00
PLRZ balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 158000.00
PLRZ balance_sheet (annual, 2023-12-31) — Current Assets: 54000.00
PLRZ balance_sheet (annual, 2023-12-31) — Current Debt: 200000.00
PLRZ balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 200000.00
PLRZ balance_sheet (annual, 2023-12-31) — Current Liabilities: 502000.00
PLRZ cash_flow (annual, 2023-12-31) — Depreciation: 4000.00
PLRZ cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 4000.00
PLRZ cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 4000.00
PLRZ income_statement (annual, 2023-12-31) — Diluted Average Shares: 2796.00
PLRZ income_statement (annual, 2023-12-31) — Diluted EPS: -239.27
PLRZ income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -669000.00
PLRZ income_statement (annual, 2023-12-31) — EBIT: -635000.00
PLRZ income_statement (annual, 2023-12-31) — EBITDA: -631000.00
PLRZ cash_flow (annual, 2023-12-31) — End Cash Position: 4000.00
PLRZ cash_flow (annual, 2023-12-31) — Financing Cash Flow: 505000.00
PLRZ cash_flow (annual, 2023-12-31) — Free Cash Flow: -537000.00
PLRZ cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -293000.00
PLRZ income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 265000.00
PLRZ income_statement (annual, 2023-12-31) — General And Administrative Expense: 303000.00
PLRZ balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 0.00
PLRZ income_statement (annual, 2023-12-31) — Interest Income: 0.00
PLRZ income_statement (annual, 2023-12-31) — Interest Income Non Operating: 0.00
PLRZ balance_sheet (annual, 2023-12-31) — Invested Capital: 9000.00
PLRZ cash_flow (annual, 2023-12-31) — Investing Cash Flow: 0.00
PLRZ cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 256000.00
PLRZ cash_flow (annual, 2023-12-31) — Issuance Of Debt: 249000.00
PLRZ cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
PLRZ cash_flow (annual, 2023-12-31) — Long Term Debt Payments: 0.00
PLRZ cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 256000.00
PLRZ balance_sheet (annual, 2023-12-31) — Net Debt: 196000.00
PLRZ income_statement (annual, 2023-12-31) — Net Income: -600000.00
PLRZ income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -669000.00
PLRZ income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -600000.00
PLRZ income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -600000.00
PLRZ income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -600000.00
PLRZ cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -600000.00
PLRZ income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -600000.00
PLRZ income_statement (annual, 2023-12-31) — Net Interest Income: -230000.00
PLRZ cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 0.00
PLRZ cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 249000.00
PLRZ cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 0.00
PLRZ income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -230000.00
PLRZ balance_sheet (annual, 2023-12-31) — Net PPE: 12000.00
PLRZ cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 0.00
PLRZ cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 249000.00
PLRZ balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -191000.00
PLRZ balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 493000.00
PLRZ income_statement (annual, 2023-12-31) — Normalized EBITDA: -896000.00
PLRZ income_statement (annual, 2023-12-31) — Normalized Income: -865000.00
PLRZ cash_flow (annual, 2023-12-31) — Operating Cash Flow: -537000.00
PLRZ cash_flow (annual, 2023-12-31) — Operating Gains Losses: -293000.00
PLRZ income_statement (annual, 2023-12-31) — Operating Income: -635000.00
PLRZ income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
PLRZ balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 2796.00
PLRZ balance_sheet (annual, 2023-12-31) — Other Current Assets: 13000.00
PLRZ balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 200000.00
PLRZ balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 105000.00
PLRZ balance_sheet (annual, 2023-12-31) — Other Equity Interest: -196000.00
PLRZ income_statement (annual, 2023-12-31) — Other Gand A: 135000.00
PLRZ income_statement (annual, 2023-12-31) — Other Income Expense: 265000.00
PLRZ cash_flow (annual, 2023-12-31) — Other Non Cash Items: 228000.00
PLRZ balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 37000.00
PLRZ balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 158000.00
PLRZ balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 39000.00
PLRZ balance_sheet (annual, 2023-12-31) — Preferred Securities Outside Stock Equity: 248000.00
PLRZ income_statement (annual, 2023-12-31) — Preferred Stock Dividends: 69000.00
PLRZ income_statement (annual, 2023-12-31) — Pretax Income: -600000.00
PLRZ cash_flow (annual, 2023-12-31) — Purchase Of Investment: 0.00
PLRZ cash_flow (annual, 2023-12-31) — Purchase Of PPE: 0.00
PLRZ income_statement (annual, 2023-12-31) — Reconciled Depreciation: 4000.00
PLRZ cash_flow (annual, 2023-12-31) — Repayment Of Debt: 0.00
PLRZ income_statement (annual, 2023-12-31) — Research And Development: 332000.00
PLRZ balance_sheet (annual, 2023-12-31) — Retained Earnings: -3521000.00
PLRZ income_statement (annual, 2023-12-31) — Salaries And Wages: 168000.00
PLRZ cash_flow (annual, 2023-12-31) — Sale Of Investment: 0.00
PLRZ income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 0.00
PLRZ income_statement (annual, 2023-12-31) — Selling General And Administration: 303000.00
PLRZ balance_sheet (annual, 2023-12-31) — Share Issued: 2796.00
PLRZ cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 249000.00
PLRZ cash_flow (annual, 2023-12-31) — Stock Based Compensation: 100000.00
PLRZ balance_sheet (annual, 2023-12-31) — Stockholders Equity: -191000.00
PLRZ balance_sheet (annual, 2023-12-31) — Tangible Book Value: -191000.00
PLRZ income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
PLRZ income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
PLRZ balance_sheet (annual, 2023-12-31) — Total Assets: 559000.00
PLRZ balance_sheet (annual, 2023-12-31) — Total Capitalization: -191000.00
PLRZ balance_sheet (annual, 2023-12-31) — Total Debt: 200000.00
PLRZ balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -191000.00
PLRZ income_statement (annual, 2023-12-31) — Total Expenses: 635000.00
PLRZ balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 750000.00
PLRZ balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 505000.00
PLRZ balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 248000.00
PLRZ income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -635000.00
PLRZ income_statement (annual, 2023-12-31) — Total Other Finance Cost: 230000.00
PLRZ income_statement (annual, 2023-12-31) — Total Unusual Items: 265000.00
PLRZ income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 265000.00
PLRZ cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: 17000.00
PLRZ balance_sheet (annual, 2023-12-31) — Working Capital: -448000.00
PLRZ income_statement (annual, 2024-12-31) — +Operating Expense: 1302000.00
PLRZ income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
PLRZ balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 10352000.00
PLRZ balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 10352000.00
PLRZ income_statement (annual, 2024-12-31) — Basic Average Shares: 1994.00
PLRZ income_statement (annual, 2024-12-31) — Basic EPS: -805.20
PLRZ cash_flow (annual, 2024-12-31) — Beginning Cash Position: 4000.00
PLRZ balance_sheet (annual, 2024-12-31) — Capital Stock: 0.00
PLRZ balance_sheet (quarterly, 2024-12-31) — Capital Stock: 0.00
PLRZ balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 2554000.00
PLRZ balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 2554000.00
PLRZ balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 2554000.00
PLRZ balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 2554000.00
PLRZ cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 3668000.00